A multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein Ilb/IIIa blocker Integrelin in elective coronary intervention - Tcheng, J E; Ellis, S G; Kleiman, N S (Circulation, 1995)
in press